No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
NTRA240719C110000
- 2.68
- -2.22-45.31%
15min DelayClose Jul 17 16:00 ET
2.68High2.68Low
2.68Open4.90Pre Close1 Volume37 Open Interest110.00Strike Price268.00Turnover58.89%IV2.09%PremiumJul 19, 2024Expiry Date0.37Intrinsic Value100Multiplier2DDays to Expiry2.31Extrinsic Value100Contract SizeAmericanOptions Type0.5406Delta0.0765Gamma48.51Leverage Ratio-0.5126Theta0.0037Rho26.23Eff Leverage0.0350Vega
Intraday
- 5D
- Daily
News
Natera, Inc.'s (NASDAQ:NTRA) Business Is Yet to Catch Up With Its Share Price
It's not a stretch to say that Natera, Inc.'s (NASDAQ:NTRA) price-to-sales (or "P/S") ratio of 11.6x right now seems quite "middle-of-the-road" for companies in the Biotechs industry in the United
These Are the Stocks With the Highest Increase in Short Interest Within Life Sciences and Diagnostics - Baird
Optimistic Outlook for Natera's Growth Potential Based on ALTAIR Trial and MRD Market Opportunity
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,300 Today
Natera (NASDAQ:NTRA) has outperformed the market over the past 5 years by 19.94% on an annualized basis producing an average annual return of 33.11%. Currently, Natera has a market capitalization of $
Jefferies Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $142
Jefferies analyst Tycho Peterson maintains $Natera(NTRA.US)$ with a buy rating, and maintains the target price at $142.According to TipRanks data, the analyst has a success rate of 55.1% and a total a
Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Natera (NTRA) and Argenx Se (ARGX)
Comments
Natera's balance sheet is healthy with net cash, indicating it could easily pay off its debt. Despite a negative free cash outflow and accounting loss last year, its revenue growth suggests potential profitability.
Does Natera (NASDAQ:NTRA) Have A Healthy Balance Sheet? 1
Natera, Inc.'s low P/S ratio is due to its forecasted growth being lower than the industry. Investors expect limited future growth and are willing to pay less for the stock. These conditions form a barrier for the share price.
3
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Atlassian(TEAM.US$ - up 15.4%
2. $Natera(NTRA.US$ - up 10.9%
3. $Universal Display(OLED.US$ - up 7.6%
4. $Amazon(AMZN.US$ - up 7.3%
5. $BWX Technologies(BWXT.US$ - up 5.7%
6. $Cloudflare(NET.US$ - up 3.9%
7. $Booking Holdings(BKNG.US$ - up 3.5%
8. $DaVita(DVA.US$ - up 3...
Gap Ups
1. $Atlassian(TEAM.US$ - up 15.4%
2. $Natera(NTRA.US$ - up 10.9%
3. $Universal Display(OLED.US$ - up 7.6%
4. $Amazon(AMZN.US$ - up 7.3%
5. $BWX Technologies(BWXT.US$ - up 5.7%
6. $Cloudflare(NET.US$ - up 3.9%
7. $Booking Holdings(BKNG.US$ - up 3.5%
8. $DaVita(DVA.US$ - up 3...
+14
12
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Korea Electric Power(KEP.US$ - up 3.1%
2. $POSCO(PKX.US$ - up 1.5%
3. $Enlink Midstream(ENLC.US$ - up 1.2%
4. $The Timken(TKR.US$ - up 1.2%
5. $Banco Bilbao Vizcaya Argentaria(BBVA.US$ - up 1.0%
6. $Option Care Health(OPCH.US$ - up 0.8%
7. $STMicroelectronics(STM.US$ - ...
Gap Ups
1. $Korea Electric Power(KEP.US$ - up 3.1%
2. $POSCO(PKX.US$ - up 1.5%
3. $Enlink Midstream(ENLC.US$ - up 1.2%
4. $The Timken(TKR.US$ - up 1.2%
5. $Banco Bilbao Vizcaya Argentaria(BBVA.US$ - up 1.0%
6. $Option Care Health(OPCH.US$ - up 0.8%
7. $STMicroelectronics(STM.US$ - ...
+17
11
1
Read more